The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of�…

Although data on the incidence and severity of new coronavirus disease 2019 (COVID-19)
due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection showed�…

OBJECTIVES: To assess the outcomes of pediatric patients with laboratory-confirmed
coronavirus disease (COVID-19) with or without multisystem inflammatory syndrome in�…

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people�…

COVID-19, a severe viral respiratory infection caused by SARS-CoV-2, affects all age
groups, yet it is more severe in elderly and individuals with co-morbidities. Recently, a�…

Background Multisystem inflammatory syndrome in children (MIS-C) is a serious health
condition that develops from and is linked to coronavirus disease 2019. MIS-C is considered�…

Abstract During the SARS-CoV-2-associated infection (COVID-19), pandemic initial reports
suggested relative sparing of children inversely related to their age. Children and neonates�…

Background As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including
more than 285,000 deaths have been reported to WHO. The risk of severe disease and�…

To conduct a systematic review and meta‐analysis to characterize inflammatory markers in
comparisons of multisystem inflammatory syndrome in children (MIS‐C) versus severe/non�…

OBJECTIVES: We aimed to measure severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) serological responses in children hospitalized with multisystem inflammatory�…